Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction

Nicotine and Tobacco Research

Volumn 15, Issue 7, 2013, Pages 1230-1238

  Kang, Si Hyuck ^a,b   Suh, Jung Won ^a,b   Choi, Dong Ju ^a,b   Chae, In Ho ^a,b   Cho, Goo Yeong ^a,b   Youn, Tae Jin ^a,b   Cho, Young Seok ^a,b   Yoon, Chang Hwan ^a,b   Oh, Il Young ^a,b   Cho, Myeong Chan ^c   Kim, Young Jo ^d   Chae, Shung Chull ^e   Kim, Joo Han ^f   Ahn, Young Keun ^f   Jeong, Myung Ho ^f  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chungbuk National University Hospital   (South Korea)

^d Young Nam University Hospital   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPUBLIC OF KOREA; RISK FACTORS; SMOKING;

EID: 84879362247     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts248     Document Type: Article

References (29)

1. Aune, E., Endresen, K., Roislien, J., Hjelmesaeth, J., & Otterstad, J. E. (2010). The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction. BMC Cardiovascular Disorders, 10, 59.
2. Barbash, G. I., Reiner, J., White, H. D., Wilcox, R. G., Armstrong, P. W., Sadowsi, Z. M., . . . Allan M. (1995). Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Journal of the American College of Cardiology, 26(5), 1222-1229. doi:10.1016/0735-1097(95)00299-5
3. Barbash, G. I., White, H. D., Modan, M., Diaz, R., Hampton, J. R., Heikkila, J., Van der Werf, T. (1993). Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation, 87(1), 53-58.
4. Berger, J. S., Bhatt, D. L., Steinhubl, S. R., Shao, M., Steg, P. G., Montalescot, G., Berger, P. B. (2009). Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation, 120(23), 2337-2344. doi: CIRCULATIONAHA.109.866533
5. Bliden, K. P., Dichiara, J., Lawal, L., Singla, A., Antonino, M. J., Baker, B. A., Gurbel, P. A. (2008). The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. Journal of American College of Cardiology, 52(7), 531-533. doi:S0735-1097(08)01836-6
6. Chen, K. Y., Rha, S. W., Li, Y. J., Poddar, K. L., Jin, Z., Minami, Y., Park, S. J. (2009). Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation, 119(25), 3207-3214. doi:CIRCULATI ONAHA.108.822791
7. Critchley, J., & Capewell, S. (2004). Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database of Systematic Review (1), CD003041. doi:10.1002/14651858.CD003041.pub2
8. Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G. A., Serruys, P. W. (2007). Clinical end points in coronary stent trials: A case for standardized definitions. Circulation, 115(17), 2344-2351. doi:115/17/2344
9. D'Agostino, R. B., Jr. (1998). Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine, 17(19), 2265-2281. doi:10.1002/(SICI)1097- 0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
10. Desai, N. R., Mega, J. L., Jiang, S., Cannon, C. P., & Sabatine, M. S. (2009). Interaction between cigarette smoking and clinical benefit of clopidogrel. Journal of American College of Cardiology, 53(15), 1273-1278. doi:S0735-1097(09)00286-1
11. Doll, R., & Peto, R. (1976). Mortality in relation to smoking: 20 years' observations on male British doctors. British Medical Journal, 2(6051), 1525-1536.
12. Doo, Y.-C., Kim, J.-S., Chae, K.-S., Song, K.-W., Hong, K.-S., Park, D.-G., Lee, Yung. (1999). Clinical and angiographic characteristics and long-term follow-up in patients with variant angina who presented as acute myocardial infarction. Korean Circulation Journal, 29(3), 276-284.
13. Galanakis, D. K., Laurent, P., & Janoff, A. (1982). Cigarette smoke contains anticoagulants against fibrin aggregation and factor XIIIa in plasma. Science, 217(4560), 642-645.
14. Gottlieb, S., Boyko, V., Zahger, D., Balkin, J., Hod, H., Pelled, B., Behar, S. (1996). Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey). Journal of the American College of Cardiology, 28(6), 1506-1513. doi:10.1016/s0735- 1097(96)00334-8
15. Gourlay, S. G., Rundle, A. C., & Barron, H. V. (2002). Smoking and mortality following acute myocardial infarction: Results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine & Tobacco Research, 4(1), 101-107. doi:10.1080/14622200110103205
16. Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., Fox, K. A. (2003). Predictors of hospital mortality in the global registry of acute coronary events. Archives of Internal Medicine, 163(19), 2345-2353. doi:10.1001/archinte.163.19.2345 163/19/2345
17. Grines, C. L., Topol, E. J., O'Neill, W. W., George, B. S., Kereiakes, D., Phillips, H. R., Califf, Robert M. (1995). Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation, 91(2), 298-303.
18. Himbert, D., Klutman, M., Steg, G., White, K., & Gulba, D. C. (2005). Cigarette smoking and acute coronary syndromes: A multinational observational study. International Journal of Cardiology, 100(1), 109-117.
19. Kelly, T. L., Gilpin, E., Ahnve, S., Henning, H., & Ross, J., Jr. (1985). Smoking status at the time of acute myocardial infarction and subsequent prognosis. American Heart Journal, 110(3), 535-541.
20. Kim, W., Jeong, M. H., Gill, G. C., Jeong, W. G., Hong, Y. J., Lee, S. H., Kang, J. C. (2003). The clinical outcome of acute myocardial infarction with normal coronary angiogram. Korean Circulation Journal, 33(1), 15-21.
21. Kirtane, A. J., Martinezclark, P., Rahman, A. M., Ray, K. K., Karmpaliotis, D., Murphy, S. A., Gibson, C. M. (2005). Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of American College of Cardiology, 45(2), 321-323. doi:S0735-1097(04)02035-2
22. Libby, P., Bonow, R. O., Mann, D. L., & Zipes, D. P. (2007). Braunwald's heart disease: A textbook of cardiovascular medicine. Philadelphia, PA: Elsevier Health Sciences.
23. Park, K. W., Park, J. J., Jeon, K. H., Kang, S. H., Oh, I. Y., Yang, H. M., Kim, H. S. (2011). Enhanced clopidogrel responsiveness in smokers: Smokers' paradox is dependent on cytochrome P450 CYP1A2 status. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(3), 665-671. doi:ATVBAHA.110.217182
24. Peto, R., Boreham, J., Lopez, A. D., Thun, M., & Heath, C. (1992). Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. The Lancet, 339(8804), 1268-1278. doi:10.1016/0140-6736(92)91600-d
25. Price, M. J., Nayak, K. R., Barker, C. M., Kandzari, D. E., & Teirstein, P. S. (2009). Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. American Journal of Cardiology, 103(10), 1339-1343. doi:S0002-9149(09)00458-5
26. Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70, 41-55.
27. Sambola, A., Osende, J., Hathcock, J., Degen, M., Nemerson, Y., Fuster, V., Badimon, J. J. (2003). Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation, 107(7), 973-977.
28. Shah, A. M., Pfeffer, M. A., Hartley, L. H., Moye, L. A., Gersh, B. J., Rutherford, J. D., Rutherford, J. D., Lamas, G. A., Solomon, S. D. (2010). Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. American Journal of Cardiology, 106(7), 911-916. doi:S0002-9149(10)01121-5
29. Yasue, H., & Kugiyama, K. (1997). Coronary spasm: Clinical features and pathogenesis. Internal Medicine, 36(11), 760-765.